Scientists mine patient blood for new weapons against superbug
NCT ID NCT04335383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop new antibody treatments for Pseudomonas aeruginosa, a bacteria that can be resistant to many antibiotics. Researchers will collect blood from 30 patients who have had this infection to isolate and produce antibodies that can fight the bacteria. The goal is to find an alternative to antibiotics for treating these hard-to-kill infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI-ANTIBIOTIC RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Grenoble Alpes
RECRUITINGGrenoble, 38043, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tracking superbugs from mother to baby: a chicago study
- New antibiotic combo shows promise against superbug infections
- New study tests best antibiotic for superbug infections
- French study monitors how new antibiotics are used in kids with superbug infections
- Poop pills vs. superbugs: can a fecal transplant beat resistant gut bacteria?
- Scientists hunt superbug in water and people to stop its spread